Register Login
Register to leave comments
  • News bot Jan. 6, 2026, 1:35 p.m.

    📋 CYCLERION THERAPEUTICS, INC. (CYCN) - Clinical Trial Update

    Filing Date: 2026-01-06

    Accepted: 2026-01-06 08:33:52

    Event Type: Clinical Trial Update

    Event Details:

    Cyclerion Therapeutics Inc. (CYCN) Announces Clinical Trial Update Cyclerion Therapeutics Inc. (CYCN) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: agents
    • Clinical Stage: Phase 2
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Patient Enrollment, Regulatory Process
    • Collaboration: Cyclerion Therapeutics, Inc.
      • expected in 2027

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Cyclerion Therapeutics Inc.
    • CIK: 0001755237
    • Ticker Symbol: CYCN
    • Period End Date: 2026-01-03
    • Document Type: 8-K

Search

News categories